Tag: pancreatic cancer

May 13, 2019

AngioDynamics Announces First Patient Enrolled in NanoKnife® DIRECT Clinical Study

AngioDynamics (NASDAQ:ANGO) has announced it has enrolled the first patient in its NanoKnife Irreversible Electroporation (IRE) “Data IRE Cancer Treatment”...
April 3, 2019

TYME Secures Capital to Advance Pivotal Studies of SM-88 in Metastatic Pancreatic Cancer

Tyme Technologies (NASDAQ:TYME) has announced the closing of an underwritten registered offering with three existing investors and one new investor...
February 25, 2019

TYME Receives FDA Guidance on Pivotal Trial for SM-88 in Treatment for Advanced Pancreatic Cancer

Tyme Technologies (NASDAQ:TYME) has announced it has received design guidance for a registrational trial from the US Food and Drug...
May 7, 2018

Rexahn Reports First Quarter 2018 Financial Results

Rexahn Pharmaceuticals (NYSE American:RNN), a clinical stage biopharmaceutical company developing innovative, targeted therapeutics for the treatment of cancer, announced financial...
April 30, 2018

8 Glioblastoma Treatment Stocks

With an average survival rate of 16 months, glioblastoma is the most common and deadly type of brain cancer, accounting...
April 18, 2018

Biotech Update: Q1 2018 in Review

With Q1 2018 behind us, here the Investing News Network looks back on some of the biggest trends of the...
April 16, 2018

Shire plc : Shire Announces Sale of Oncology Business to Servier for $2.4 Billion

Shire (LSE: SHP, NASDAQ: SHPG) the leading global biotechnology company focused on rare diseases announces today that it has entered...